Risk Factors for Rehospitalization Within 90 Days in Patients with Inflammatory Bowel Disease
- PMID: 26244647
- PMCID: PMC5189985
- DOI: 10.1097/MIB.0000000000000537
Risk Factors for Rehospitalization Within 90 Days in Patients with Inflammatory Bowel Disease
Abstract
Background: Care of patients with inflammatory bowel disease (IBD) poses a significant burden to the health-care system. Repeat hospitalization in subgroups of IBD patients seems to be a large part of this issue; however, there are limited data examining the characteristics of these patients. The aim of this study was to characterize admission patterns in patients with IBD at a tertiary-care center and to identify preventable risk factors of 90-day readmission after an index IBD admission.
Methods: Retrospective analysis was performed extracting data from an electronic medical record over a 2-year period.
Results: Three hundred fifty-six patients were admitted at least once during the 2-year study period for an unplanned IBD-related reason. Of these, 48.9% were admitted once, 38.2% were admitted 2 to 4 times, and 12.9% were admitted 5 or more times during the study period. Patients with any admission within 90 days before index were excluded; n = 33. One hundred two patients had experienced a readmission by 90 days after index admission. Numerous demographic and medical factors were examined for association with readmission. The final Cox model included 3 variables: depression (HR = 1.99, 1.33-3.00), chronic pain (HR = 1.88, 1.14-3.10), and steroid use in the previous 6 months (HR = 1.33, 0.92-2.04).
Conclusions: Our findings suggest that patients with depression and chronic pain are at greatest risk for a readmission within 90 days after an initial IBD admission. Disease activity, represented by steroid use in the previous 6 months, was not related to readmission. Addressing these problems in the outpatient setting may reduce future hospitalizations.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures
References
-
- van Langenberg DR, Simon SB, Holtmann GJ, et al. The burden of inpatient costs in inflammatory bowel disease and opportunities to optimize care: a single metropolitan Australian center experience. J Crohns Colitis. 2010;4:413–421. - PubMed
-
- Bernstein CN, Longobardi T, Finlayson G, et al. Direct medical cost of managing IBD patients: a Canadian population-based study. Inflamm Bowel Dis. 2012;18:1498–1508. - PubMed
-
- Nabalamba A, Bernstein CN, Seko C. Inflammatory bowel disease–hospitalization. Health Rep. 2004;15:25–40. - PubMed
-
- Nguyen GC, Bollegala N, Chong CA. Factors associated with readmissions and outcomes of patients hospitalized for inflammatory bowel disease. Clin Gastroenterol Hepatol. 2014;12:1897–1904. e1. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
